92 related articles for article (PubMed ID: 3007415)
1. Distinct isozyme patterns of cyclic nucleotide phosphodiesterase in human neuroblastoma and ganglioneuroma; a possible marker of differentiation of neural crest-derived tumors and Schwann cells.
Nagai T; Todo S; Imashuku S
Jpn J Cancer Res; 1986 Jan; 77(1):52-8. PubMed ID: 3007415
[TBL] [Abstract][Full Text] [Related]
2. Cellular distribution and pharmacological sensitivity of low Km cyclic nucleotide phosphodiesterase isozymes in human cardiac muscle from normal and cardiomyopathic subjects.
Silver PJ; Allen P; Etzler JH; Hamel LT; Bentley RG; Pagani ED
Second Messengers Phosphoproteins; 1990; 13(1):13-25. PubMed ID: 2286932
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
Yu H; Cai JJ; Lee HC
Mol Pharmacol; 1996 Sep; 50(3):549-55. PubMed ID: 8794893
[TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotide phosphodiesterase isozymes in neuroblastoma cells.
Watz MA; Holt IL; Howlett AC
J Neurosci Res; 1987; 17(3):291-7. PubMed ID: 3037096
[TBL] [Abstract][Full Text] [Related]
5. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
Barnette MS; Manning CD; Price WJ; Barone FC
J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
[TBL] [Abstract][Full Text] [Related]
6. Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters.
Masunaga R; Nagasaka A; Sawai Y; Hayakawa N; Nakai A; Hotta K; Kato Y; Hishida H; Takahashi H; Naka M; Shimada Y; Tanaka T; Hidaka H; Itoh M
J Mol Cell Cardiol; 2004 Sep; 37(3):767-74. PubMed ID: 15350849
[TBL] [Abstract][Full Text] [Related]
7. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
Torphy TJ; Undem BJ; Cieslinski LB; Luttmann MA; Reeves ML; Hay DW
J Pharmacol Exp Ther; 1993 Jun; 265(3):1213-23. PubMed ID: 8389856
[TBL] [Abstract][Full Text] [Related]
8. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
Zhou L; Thompson WJ; Potter DE
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
[TBL] [Abstract][Full Text] [Related]
9. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
Bode DC; Hamel LT; Wax MB
J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
[TBL] [Abstract][Full Text] [Related]
10. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
[TBL] [Abstract][Full Text] [Related]
11. Induction of the regulatory subunit of type I adenosine cyclic 3':5'-monophosphate-dependent protein kinase in differentiated N-18 mouse neuroblastoma cells.
Liu AY; Chan T; Chen KY
Cancer Res; 1981 Nov; 41(11 Pt 1):4579-87. PubMed ID: 6272981
[TBL] [Abstract][Full Text] [Related]
12. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
Drees M; Zimmermann R; Eisenbrand G
Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 3':5' cyclic nucleotide phosphodiesterase activities of mouse neuroblastoma N18TG2 cells.
Giorgi M; Caniglia C; Scarsella G; Augusti-Tocco G
FEBS Lett; 1993 Jun; 324(1):76-80. PubMed ID: 8389302
[TBL] [Abstract][Full Text] [Related]
14. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
15. A new cyclic nucleotide phosphodiesterase isozyme expressed in the T-lymphocyte cell lines.
Ichimura M; Kase H
Biochem Biophys Res Commun; 1993 Jun; 193(3):985-90. PubMed ID: 8391815
[TBL] [Abstract][Full Text] [Related]
16. Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme.
Kakkar R; Raju RV; Rajput AH; Sharma RK
Brain Res; 1997 Feb; 749(2):290-4. PubMed ID: 9138729
[TBL] [Abstract][Full Text] [Related]
17. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
18. Characterization by DEAE-cellulose chromatography of a single molecular form of cyclic nucleotide phosphodiesterase in the myometrium of nonpregnant women.
Leroy MJ; Blot P; Ferré F
Gynecol Obstet Invest; 1987; 24(3):190-9. PubMed ID: 2826314
[TBL] [Abstract][Full Text] [Related]
19. Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro.
Ross RA; Biedler JL
Cancer Res; 1985 Apr; 45(4):1628-32. PubMed ID: 2983884
[TBL] [Abstract][Full Text] [Related]
20. Assessment of phosphodiesterase isozyme contribution in cell and tissue extracts.
Keravis T; Thaseldar-Roumié R; Lugnier C
Methods Mol Biol; 2005; 307():63-74. PubMed ID: 15988055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
